PROFILO, MARIA ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 672
EU - Europa 329
AS - Asia 135
AF - Africa 23
SA - Sud America 2
OC - Oceania 1
Totale 1.162
Nazione #
US - Stati Uniti d'America 657
SE - Svezia 112
CN - Cina 77
IT - Italia 73
DE - Germania 40
BG - Bulgaria 30
SG - Singapore 25
GB - Regno Unito 24
FR - Francia 17
CI - Costa d'Avorio 15
CA - Canada 14
AT - Austria 12
VN - Vietnam 12
IN - India 8
RU - Federazione Russa 7
SN - Senegal 7
FI - Finlandia 6
TR - Turchia 6
UA - Ucraina 6
HK - Hong Kong 5
AU - Australia 1
BD - Bangladesh 1
BE - Belgio 1
BR - Brasile 1
CL - Cile 1
JP - Giappone 1
LT - Lituania 1
MA - Marocco 1
PA - Panama 1
Totale 1.162
Città #
Houston 88
Ann Arbor 69
Fairfield 69
Woodbridge 62
Seattle 50
Chandler 48
Santa Clara 47
Ashburn 41
Serra 38
Sofia 30
Cambridge 28
Wilmington 26
Shanghai 16
Abidjan 15
New York 14
Singapore 14
Beijing 12
London 12
Ottawa 12
Vienna 12
Princeton 10
Boardman 9
Bremen 9
Florence 9
Lawrence 9
Dearborn 8
Nanjing 8
Dakar 7
Des Moines 7
Lancaster 7
Marseille 7
Medford 7
Ogden 7
Dong Ket 6
Aosta 5
Fuzhou 5
Frankfurt am Main 4
Hong Kong 4
Istanbul 4
Kunming 4
Munich 4
Nanchang 4
Hefei 3
Jüchen 3
Manchester 3
Da Nang 2
Englewood 2
Hebei 2
Izmir 2
Jacksonville 2
Redwood City 2
San Diego 2
San Francisco 2
Toronto 2
Wuhan 2
Xiamen 2
Brussels 1
Changsha 1
Chengdu 1
Chicago 1
Conshohocken 1
Dallas 1
Düsseldorf 1
Grafing 1
Guangzhou 1
Helsinki 1
Highland 1
Jinan 1
Lanzhou 1
Melbourne 1
Ningbo 1
Palm City 1
Panama City 1
Pune 1
Quanzhou 1
Rome 1
Santiago 1
Shenyang 1
Tianjin 1
Totale 901
Nome #
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 162
Optic neuropathy in 2 thyroidectomized patients with moderate to severe Graves’ ophthalmopathy following L-thyroxine withdrawal prior to radioiodine treatment for thyroid carcinoma 126
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 126
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 122
null 121
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 106
null 97
null 91
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study 84
Hypothyroidism Due to L-T4 Withdrawal Can Precipitate Optic Neuropathy in Patients with Moderate to Severe Graves' Ophthalmopathy: Report on Two Cases 80
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy 43
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy 34
Totale 1.192
Categoria #
all - tutte 3.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020105 0 0 0 0 0 0 24 18 21 13 24 5
2020/202188 9 5 4 3 16 1 7 5 12 8 7 11
2021/2022156 1 3 0 11 34 14 2 4 37 14 1 35
2022/2023198 23 44 17 15 14 16 2 12 42 0 11 2
2023/202476 2 5 8 0 10 15 0 11 2 2 13 8
2024/2025120 0 11 6 21 43 31 8 0 0 0 0 0
Totale 1.192